Xiaoping Xu

7.2k total citations · 2 hit papers
161 papers, 4.8k citations indexed

About

Xiaoping Xu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaoping Xu has authored 161 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 33 papers in Cancer Research and 22 papers in Oncology. Recurrent topics in Xiaoping Xu's work include RNA modifications and cancer (18 papers), Protease and Inhibitor Mechanisms (15 papers) and Peptidase Inhibition and Analysis (12 papers). Xiaoping Xu is often cited by papers focused on RNA modifications and cancer (18 papers), Protease and Inhibitor Mechanisms (15 papers) and Peptidase Inhibition and Analysis (12 papers). Xiaoping Xu collaborates with scholars based in China, United States and France. Xiaoping Xu's co-authors include Tripathi B. Rajavashisth, Prediman K. Shah, Sanjay Kaul, Bjorn Steffensen, Michael C. Fishbein, Behrooz G. Sharifi, Simcha Meisel, Bojan Cercek, Zhihua Chen and Ozlem Equils and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Xiaoping Xu

146 papers receiving 4.7k citations

Hit Papers

A peptide encoded by circu... 2001 2026 2009 2017 2018 2001 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A peptide encoded by circular form of LINC-PINT suppresses oncogenic transcriptional elongation in glioblastoma
    2018 548 citations Xiaoping Xu et al. Nature Communications profile →
  2. Toll-Like Receptor-4 Is Expressed by Macrophages in Murine and Human Lipid-Rich Atherosclerotic Plaques and Upregulated by Oxidized LDL
    2001 526 citations Xiaoping Xu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoping Xu China 37 2.3k 1.4k 799 541 447 161 4.8k
Kouichi Ozaki Japan 36 2.5k 1.1× 904 0.6× 682 0.9× 388 0.7× 482 1.1× 118 5.0k
Simon Koplev United States 14 4.0k 1.7× 1.2k 0.8× 1.1k 1.4× 690 1.3× 428 1.0× 18 6.6k
Carsten Sticht Germany 41 4.5k 2.0× 2.7k 1.9× 845 1.1× 803 1.5× 561 1.3× 179 7.6k
P. Naresh Kumar United States 5 3.7k 1.6× 741 0.5× 415 0.5× 462 0.9× 417 0.9× 7 6.5k
Ken Matsumoto Japan 46 4.9k 2.1× 919 0.6× 800 1.0× 592 1.1× 314 0.7× 222 7.8k
Reinhold Schäfer Germany 41 3.8k 1.6× 1.1k 0.8× 961 1.2× 1.3k 2.4× 254 0.6× 132 5.9k
Andrew D. Rouillard United States 12 4.9k 2.1× 1.3k 0.9× 1.1k 1.4× 821 1.5× 525 1.2× 17 8.1k
Martin Eisenacher Germany 41 5.4k 2.3× 780 0.5× 856 1.1× 840 1.6× 333 0.7× 163 8.6k
Caroline D. Monteiro United States 6 4.5k 1.9× 1.3k 0.9× 1.1k 1.3× 768 1.4× 406 0.9× 6 7.1k

Countries citing papers authored by Xiaoping Xu

Since Specialization
Citations

This map shows the geographic impact of Xiaoping Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Xu more than expected).

Fields of papers citing papers by Xiaoping Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoping Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Xu. The network helps show where Xiaoping Xu may publish in the future.

Co-authorship network of co-authors of Xiaoping Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoping Xu. A scholar is included among the top collaborators of Xiaoping Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoping Xu. Xiaoping Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Ma, Yucheng, et al.. (2025). Multi-omics analysis identifies a microbiota–bile acid–TLR signaling axis driving bladder injury in interstitial cystitis. Nature Communications. 17(1). 1299–1299. 1 indexed citations
5.
Xu, Xiaoping, et al.. (2025). Molecular basis of EWS interdomain self‐association and its role in condensate formation. Protein Science. 34(10). e70316–e70316.
6.
7.
Xu, Xiaoping, et al.. (2025). Global research trends in music therapy for surgery: a bibliometric analysis (2009–2023). Perioperative Medicine. 14(1). 12–12.
8.
Ou, Minrui, et al.. (2025). In silico toxicology investigation of μ-conotoxin KIIIA on human Na+ channel Nav1.2. International Journal of Biological Macromolecules. 298. 140092–140092.
9.
Cai, Zhaowei, Yingying Fan, Yujie Ren, et al.. (2023). Dysregulation of Ceramide Metabolism Is Linked to Iron Deposition and Activation of Related Pathways in the Aorta of Atherosclerotic Miniature Pigs. Antioxidants. 13(1). 4–4. 10 indexed citations
10.
Yang, Dan, Jiaxin Liu, Yansong Song, et al.. (2023). MRTF‐A / SRF signaling suppresses invasion of oral squamous cell carcinoma. Oral Diseases. 30(4). 1919–1934. 1 indexed citations
11.
Feng, Lei, Yi Wang, Yu Fu, et al.. (2023). A simple and efficient strategy for cell‐based and cell‐free‐based therapies in acute liver failure: hUCMSCs bioartificial liver. Bioengineering & Translational Medicine. 8(5). e10552–e10552. 6 indexed citations
12.
13.
Xu, Xiaoping, et al.. (2023). Development and validation of a two glycolysis-related LncRNAs prognostic signature for glioma and in vitro analyses. Cell Division. 18(1). 10–10. 3 indexed citations
14.
Xu, Xiaoping, et al.. (2022). Comprehensive Analysis of Prognostic Value and Immune Infiltration of IGFBP Family Members in Glioblastoma. Journal of Healthcare Engineering. 2022. 1–13. 7 indexed citations
15.
Chen, Dong, Xiaoping Xu, Yuan Pan, et al.. (2022). MYC-activated CERS6-AS1 sponges miR-6838-5p and regulates the expression of RUBCNL in colorectal cancer. Cellular and Molecular Biology. 68(12). 42–48. 4 indexed citations
16.
Feng, Lei, Yi Wang, Yu Fu, et al.. (2021). UGT1A Gene Family Members Serve as Potential Targets and Prognostic Biomarkers for Pancreatic Cancer. BioMed Research International. 2021(1). 6673125–6673125. 5 indexed citations
17.
Yu, Wei, Yingjian Zhang, Xiaoping Xu, et al.. (2020). A Prospective Trial of 68Ga-PSMA and 18F-FDG PET/CT in Nonmetastatic Prostate Cancer Patients with an Early PSA Progression During Castration. Clinical Cancer Research. 26(17). 4551–4558. 49 indexed citations
18.
Mao, Xiaowen, Sze Keong Tey, Cherlie Lot Sum Yeung, et al.. (2020). Nidogen 1‐Enriched Extracellular Vesicles Facilitate Extrahepatic Metastasis of Liver Cancer by Activating Pulmonary Fibroblasts to Secrete Tumor Necrosis Factor Receptor 1. Advanced Science. 7(21). 2002157–2002157. 72 indexed citations
19.
Seo, Kinya, Peter P. Rainer, Virginia S. Hahn, et al.. (2014). Combined TRPC3 and TRPC6 blockade by selective small-molecule or genetic deletion inhibits pathological cardiac hypertrophy. Proceedings of the National Academy of Sciences. 111(4). 1551–1556. 160 indexed citations
20.
Csank, Adam, C. I. Czimczik, Xiaoping Xu, & J. M. Welker. (2011). Seasonal Shifts In The Source And Age Of Riverine DOC And POC in NW Greenland. AGU Fall Meeting Abstracts. 2011. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kouichi Ozaki Breakdown of academic impact, for papers by Simon Koplev Breakdown of academic impact, for papers by Carsten Sticht Breakdown of academic impact, for papers by P. Naresh Kumar Breakdown of academic impact, for papers by Ken Matsumoto Breakdown of academic impact, for papers by Reinhold Schäfer Breakdown of academic impact, for papers by Andrew D. Rouillard Breakdown of academic impact, for papers by Martin Eisenacher Breakdown of academic impact, for papers by Caroline D. Monteiro
Rankless by CCL
2026